Join NORML with at least a $35 annual donation or sign up to be a sustaining $10 monthly donation before July 1 and we’ll send you this exclusive NORML drink koozie. Chances are, marijuana is safer than what’s in that can!
Author: NORML
Federal Employment Protections Demanded In Appropriations Bill
For the first time, the House Subcommittee on Financial Services and General Government Appropriations has included language seeking to protect the employment of federal employees who consume cannabis in legal jurisdictions.
Cannabis Excelsior: Remembering Doug Greene
Doug was a passionate advocate for ending America’s failed war on cannabis consumers, and his work with NORML and for the cause spans decades not years. This is a sad loss for his friends and family, the New York cannabis community, and the legalization movement.
FDA Hearing On ‘Hemp-Derived CBD’ Today
In its written testimony, NORML Deputy Director Paul Armentano encourages the agency to act expeditiously to clarify confusion among both consumers and regulators with regard to the legality of specific CBD products. It further recommends that the FDA provide regulatory guidelines governing product manufacturing, standardization, and quality.
Illinois Senate Passes the Cannabis Regulation and Tax Act
After decades of hard work by dedicated volunteers and activists from coast-to-coast that mission is one step closer to fruition following the passage of the Cannabis Regulation and Tax Act (HB1438-SFA2) by the Illinois Senate.
Clinical Trial: CBD Administration Reduces Heroin Cravings
The administration of oral CBD reduces cue-induced cravings and anxiety in subjects with a history of heroin use, according to clinical data published in The American Journal of Psychiatry. Commenting on the study’s findings, NORML Deputy Director Paul Armentano said, “These conclusions add to the growing body of evidence that cannabis and its constituents represent an exit away from the use or abuse of other controlled substances rather than a supposed ‘gateway.'”
NORML Submits Comments to FDA Ahead of CBD Hearing
NORML has submitted written comments to the US Food and Drug Administration ahead of the agency’s scheduled hearing on the regulation CBD-infused products. The agency will be taking in person public testimony on Friday, May 31, with regard to the “manufacturing, product quality, marketing, labeling, and sale” of CBD-infused retail products.
Sen. Schumer And Rep. Jeffries To Introduce Comprehensive Marijuana Reform Legislation
Today, Senate Democratic Leader Chuck Schumer and House Democratic Caucus Chairman Hakeem Jeffries announced their intentions to introduce legislation known as the Marijuana Freedom and Opportunity Act, to remove marijuana from the Controlled Substances Act (CSA), thus ending the nearly century-long federal policy of criminalization and prohibition. Send a message to your elected officials in support of this legislation now. NORML Political Director Justin Strekal said, “The Marijuana Freedom and Opportunity Act is comprehensive legislation that would end our nation’s failed 80-year prohibition of marijuana and allow states to implement reforms free from the threat of federal interference.” “This bill is part of the continued shift of Democratic Party leadership. At a time when 68 percent of Americans support marijuana…
House Veterans Affairs Subcommittee To Hear Three Cannabis Bills
On April 30, the House Veterans’ Affairs Subcommittee on Health will hold a hearing for multiple pieces of legislation, including the VA Medicinal Cannabis Research Act, the Veterans Equal Access Act and the Veterans Cannabis Use for Safe Healing Act.
Want a new sticker for your laptop?
As we approach April 20, we’d like to take a minute to thank you for being an active supporter of NORML’s efforts to end the failed policy of marijuana prohibition.